Member Info for PlantPower

It’s just in the wrong section (should be in POC section - currently only states “affordable” not “rapid”) would have thought PCR 96 kit section would have a statement such as:

“We believe there is large international demand in terms of rapid laboratory automated high volume throughout testing solutions”.

Agreed on POC product - and kudos to Technik who has stated multiple months ago this was the product which most excited him. He also believed year-end was potentially sand bagging and expected earlier delivery (Technik - shout if misrepresenting!). Which is exciting, although not looking forward to reg approval wait again...!

PP

Also think II Seller happy to get £1 based on yesterday’s delayed sells @ £1 in volume - would have expected could have let SP rise more as lots of buying pressure but appears to have soaked it all up around £1 mark.

So:
- II Buyer happy up to £1
- II Seller happy to sell under £1

Based on above permutation - can’t see us clearing £1 without news.....

Thoughts?

PP

95k vol of what appears to be delayed sells from yesterday.

Still think II Seller is bigger than II Buyer - agree Buyer won’t pay much over £1 at this point.

Expect another chunk of delayed sells from today which put pressure on SP btw 9-11am.

Surprised no RNS for Seller - maybe as selloff still inflight.

PP

Whilst talking about potential discrepancies - thought last sentence in GDR’s new page also slightly confusing as again references POC testing:

“Genedrive® 96-SARS-CoV-2 Kit
First commercial sales July 2020 – sales into Europe
Purchase orders and indicative sales intent of over £1m – subject to regulatory approvals
Entered collaboration agreement with Beckman Coulter Life Sciences to automate Covid-19 testing – 4 August 2020
Africa, India and US are primary markets of focus
We believe there is large international demand in terms of rapid point of care testing.“

Maybe I’m missing something or just semantics...or error?

PP

Agree @Starrenstoff, thought same on initial read and subsequent re-read - my understanding is GDR 96 & BC tie up is for in lab, not in POC - eg as alluded to below (cinemas /schools):

“What does this mean in practice? If working, one Biomek devices could analyse 1000 samples in an eight hour day, which would be more than enough for many work spaces, cinemas, schools or libraries.”

“ the key to all this is the on-site automation”

Bit of lazy journo - although nice sentiment of article and nice bit of PR. POC will hopefully deliver, but appears product cross-mixed.

Although, automated 1000 samples in 8hr onsite POC (device sounds great! Wishful thinking!

PP

Sorry your frustrated - and maybe your right, who knows, maybe not, but not sure I deserve to be the lightning rod for your frustrations.

We all own our personal investment decisions - that’s the last point I’ll make.

Bonne chance.

PP

Lp - chill, I’m an investor just like you, I am not DB in disguise (not that I have an issue with DB).

My point about approvals is people, IMHO(!), shouldn’t read too much into new summary page being updated / created....that was the context (all important) of the thread / discussion earlier today.

Clearly the company will have more insight to any approval process where queries etc, but don’t believe they know exact date for any right now as clearly inflight.

Again - point in relation new investor page, this is just good housekeeping to offset numerous valid PI enquiries, so they’ve tried to address. Whether people think page is good / bad / indifferent is personal interpretation, but I don’t necessarily think this either makes RNS more likely or less likely.....IMHO...

#PeacePlantsChill

Make that 60k worth of buys & 10k sells from 12.

PP

Agreed - surely they should take this offline and strike a bulk deal ;0)

3x10k buy vols printed executed an hour ago @ 99.4/5p - reason for bouncebackability...

Never a dull moment with GDR...

PP

Ha Lp, you do blow hot and cold!

Clearly fun wkd post...thought the subject heading ‘Conspiracy Theories’ and ‘Conspiracy Ratings’ would have made that obvious.

Peace&Plants

Appears from my sat conspiracy theory post, that #1 Conspiracy won the day!:

1) No RNS lodges - continued building of positions pre expected rich news flow (0/10 Conspiracy rating)

PP

It’s also apparent how difficult it was for even The President of the Freeworld (?!?) to get ‘his’ plasma EUA through (effectively had to threaten FDA to reduce / diminish powers)....so if he’s struggling....

PP

....if not, we are all in the dark, so summary page going live doesn’t mean there will or won’t be an RNS regarding approvals (critical to all else) ahead of BC update.

I believe both SH’s @ GDR are in the same boat relating to approvals:

“ At this moment, we do not have any further indications of timescales from regulatory bodies. We recognise that many are working with large backlogs and large volumes of work.”

So not sure anything has materially changed in past 24hrs - but sentiment is a funny intangeable....clearly surge late Fri could have indicated leaky ship, but appears not (which is good to see), this also ties out with past RNS news (eg - no leak).

PeacePlantsPatience

Agreed - II still dumping, once done + news = BudTime

Super to see circa 9% Fri rise consolidated & held today.

All the technicals looking strong / positive - another crossing of the upper bollinger band today.

#Peace&Plants

....@1549 on Fri reason for initial late SP rise.

PP

Ditto Longrun - Naim, ur shameless ramping is no good for all LTH’s (and others). E.g.

- “ David Budd has been getting chirpy again - mooted as news being imminent re approvals now”
- “ One of the main focus markets for Budd and team - I’m expecting massive numbers the moment approval is gained (which is being mooted as imminent by Budd himself.)”

Please keep it sensible.

PP

Vol: 499k Buy vs 410k Sell / 26k Delayed

Disclaimer - haven’t ‘cleanedup’, as always not hugely reliable - lots of buys printed as sells today

PP

...Peel

https://www.google.co.uk/amp/s/www.technologynetworks.com/diagnostics/blog/amp/new-rna-extraction-strategies-help-mitigate-shortages-in-sars-cov-2-pcr-components-338786

Not sure if this impacts us..